Pharmacokinetics
Reports summarize pharmacokinetics research from Chelsea and Westminster Hospital NHS Trust
Published in AIDS Weekly, November 9th, 2009
In this recent report published in the Jaids - Journal of Acquired Immune Deficiency Syndromes, researchers in London, the United Kingdom conducted a study "To. assess the pharmacokinetics of etravirine once and twice daily without and with a preceding efavirenz intake period in healthy volunteers. Volunteers were randomized to receive etravirine 400 mg once daily (arm 1) or 200 mg twice daily (arm 2) for 14 days."
"All subjects underwent a washout period of 14 days and then took efavirenz 600 mg once daily for 14 days. Arm I and 2 restarted etravirine once and twice daily for 14 days. Etravirine pharmacokinetics was assessed for each phase (before and after...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-11-09)
More Articles from AIDS Weekly
- McGill University Health Centre
Research shows treating HIV-AIDS with interleukin-2 is ineffective - Antiretrovirals
New antiretrovirals data have been reported by researchers at Johns Hopkins University - Heart Disease
Researchers from Wayne State University detail new studies and findings in the area of heart disease - HIV/AIDS
Data on HIV/AIDS published by E. Sprinz and colleagues - HIV/AIDS
New HIV/AIDS study findings have been reported from K.H. Busse et al - HIV/AIDS
Recent findings from Northwestern University highlight research in HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
